Harnessing the Transformative Potential of AI for Medical Education

Needs Statement

Artificial intelligence (AI) is a relatively new technology with significant potential in healthcare if implemented in a strategic and safe manner. However, there are challenges in integrating AI into workflows because of limited foundational knowledge, ethical concerns, and insufficient exposure to practical tools that enhance efficiency and innovation. This series aims to bridge the gap between theoretical knowledge and real-world clinical practice, promote the use of research tools such as literature review automation and data analytics, and advance the application of AI-driven educational methods synergistically with the Learning Health System. By focusing on practical applications, ethical challenges, and future innovations, the series seeks to break down barriers to the implementation of AI and to foster innovation and collaboration.

Educational Objectives

At the conclusion of the activity, the participants should be able to:

• Identify competencies for artificial intelligence (AI) applications for everyday teaching activities.
• Describe the PICRAT framework as a guide to teaching about using AI.
• Discuss the integration of AI for teaching in various settings.
• Apply AI solutions to address challenges with teaching.
• Utilize AI tools for teaching while preserving learner skill development.

Target Audience

Competencies

• Patient Care and Procedural Skills
• Practice-Based Learning and Improvement
• Provide Patient-Centered Care
• Quality Improvement
• Roles/Responsibilities
• Systems-Based Practice
• Teams and Teamwork
• Utilize Informatics
• Values/Ethics for Interprofessional Practice
• Work in Interdisciplinary Teams

Activity Evaluation

Evaluation by questionnaire will address program content, presentation, and possible bias.

Educational Methods

• Lectures

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Approval

April 1, 2026 through April 31, 2028. Original release date: April 1, 2026.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.